Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Trials of antivirals in the treatment of multiple sclerosis.

Lycke J.

Acta Neurol Scand. 2017 Nov;136 Suppl 201:45-48. doi: 10.1111/ane.12839. Review.

PMID:
29068492
2.

Heat exposure and bicycling trigger recurrent aseptic meningitis: a case report.

Stuve O, Marder E, Okai A, Stettner M, Kieseier BC.

BMC Neurol. 2014 Dec 31;14:230. doi: 10.1186/s12883-014-0230-z.

3.

HSV1 and 2 detection in the CSF of multiple sclerosis patients by real-time PCR.

Koros C, Ioannidis A, Acquaviva T, Zoga M, Nikolaou C, Chatzipanagiotou S, Kossyvakis A, Anagnostouli M.

In Vivo. 2014 Nov-Dec;28(6):1201-5.

PMID:
25398824
4.

The participation of varicella zoster virus in relapses of multiple sclerosis.

Sotelo J, Ordoñez G, Pineda B, Flores J.

Clin Neurol Neurosurg. 2014 Apr;119:44-8. doi: 10.1016/j.clineuro.2013.12.020. Epub 2014 Jan 10.

PMID:
24635924
5.

Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors.

Ben Fredj N, Rotola A, Nefzi F, Chebel S, Rizzo R, Caselli E, Frih-Ayed M, Di Luca D, Aouni M.

J Neurovirol. 2012 Feb;18(1):12-9. doi: 10.1007/s13365-011-0056-z. Epub 2011 Nov 5.

PMID:
22058062
6.

Natalizumab and HSV meningitis.

Shenoy ES, Mylonakis E, Hurtado RM, Venna N.

J Neurovirol. 2011 Jun;17(3):288-90. doi: 10.1007/s13365-011-0027-4. Epub 2011 Apr 13.

7.

Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.

Mowry EM, James JA, Krupp LB, Waubant E.

Mult Scler. 2011 Jun;17(6):666-71. doi: 10.1177/1352458510394398. Epub 2011 Jan 6. Erratum in: Mult Scler. 2011 Dec;17(12):1539.

8.

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses.

Sellner J, Cepok S, Kalluri SR, Nestler A, Kleiter I, Kümpfel T, Linker R, Melms A, Menge T, Tumani H, Paul F, Hemmer B, Berthele A.

Neurochem Int. 2010 Nov;57(6):662-7. doi: 10.1016/j.neuint.2010.08.003. Epub 2010 Aug 10.

PMID:
20705110
9.

Common infectious agents in multiple sclerosis: a case-control study in children.

Krone B, Pohl D, Rostasy K, Kahler E, Brunner E, Oeffner F, Grange JM, Gärtner J, Hanefeld F.

Mult Scler. 2008 Jan;14(1):136-9. Epub 2007 Oct 17.

PMID:
17942525
10.

Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis.

Mancuso R, Delbue S, Borghi E, Pagani E, Calvo MG, Caputo D, Granieri E, Ferrante P.

J Med Virol. 2007 Feb;79(2):192-9.

PMID:
17177306
11.

Seroprevalence of herpes simplex virus type 2 in multiple sclerosis.

Hawkes CH, Giovannoni G, Keir G, Cunnington M, Thompson EJ.

Acta Neurol Scand. 2006 Dec;114(6):363-7.

PMID:
17083334
12.

Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis.

Pietropaolo V, Fioriti D, Mischitelli M, Anzivino E, Santini M, Millefiorini E, Di Rezze S, Degener AM.

New Microbiol. 2005 Jul;28(3):199-203.

PMID:
16240691
13.

Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis.

Ordoñez G, Pineda B, Garcia-Navarrete R, Sotelo J.

Arch Neurol. 2004 Apr;61(4):529-32.

PMID:
15096401
14.

Microbiology. Do chronic diseases have an infectious root?

Zimmer C.

Science. 2001 Sep 14;293(5537):1974-7. No abstract available.

PMID:
11557857
15.

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

Wandinger K, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner H, Wessel K, Kirchner H, Hennig H.

Neurology. 2000 Jul 25;55(2):178-84.

PMID:
10908887
16.

Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack.

Ferrante P, Mancuso R, Pagani E, Guerini FR, Calvo MG, Saresella M, Speciale L, Caputo D.

J Neurovirol. 2000 May;6 Suppl 2:S109-14.

PMID:
10871797
17.

T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications.

Kozovska M, Zang YC, Aebischer I, Lnu S, Rivera VM, Crowe PD, Boehme SA, Zhang JZ.

Eur J Immunol. 1998 Jun;28(6):1894-901.

18.
20.

Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system.

Bergström T, Alestig K, Svennerholm B, Horal P, Sköldenberg B, Vahlne A.

Eur J Clin Microbiol Infect Dis. 1990 Oct;9(10):751-7.

PMID:
2175706

Supplemental Content

Loading ...
Support Center